Related references
Note: Only part of the references are listed.The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma
Shin Saito et al.
BMC CANCER (2015)
Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissues
Hiroyuki Nagoya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
Hiroaki Kato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Fibroblast growth factors and their receptors in cancer
Jorgen Wesche et al.
BIOCHEMICAL JOURNAL (2011)
p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis
Michael Y. Fessing et al.
JOURNAL OF CELL BIOLOGY (2011)
Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration
G. Sonvilla et al.
BRITISH JOURNAL OF CANCER (2010)
1-tert-Butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)- pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a Selective Tyrosine Kinase Inhibitor of Fibroblast Growth Factor Receptor-3 (FGFR3), Inhibits Cell Proliferation of Bladder Cancer Carrying the FGFR3 Gene Mutation along with Up-Regulation of p27/Kip1 and G1/G0 Arrest
Makito Miyake et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
Ellen Margrethe Haugsten et al.
MOLECULAR CANCER RESEARCH (2010)
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Jing Qing et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Treatment process and tumor marker of esophageal cancer
Keio Song et al.
ESOPHAGUS (2009)
ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells
Akio Shimizu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SCC-112 gene is involved in tumor progression and promotes the cell proliferation in G2/M phase
M. Z. Zheng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Knockdown by shRNA identifes S249C mutant FGFR3 as a potential therapeutic target in bladder cancer
D. C. Tomlinson et al.
ONCOGENE (2007)
Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo
Tadanori Mammoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Receptor specificity of the fibroblast growth factor family - The complete mammalian FGF family
Xiuqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene
C Barclay et al.
CLINICAL CANCER RESEARCH (2005)
Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation
G Mostoslavsky et al.
MOLECULAR THERAPY (2005)
ΔNp63α expression is regulated by the phosphoinositide 3-kinase pathway
CE Barbieri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH
T Ishizuka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Share Paper
